Oncogenic mutations of PIK3CA (PIK3CAmut) are signature mutations in multiple cancers, which are present in approximately 30% of human breast cancer patients,9 and at a higher proportion in LBC patients,8 especially in refractory advanced disease.10, 11, 12. This evidence concerns the gene PIK3CA and breast cancer.